Skip to main content
. 2010 Oct 26;4(10):e709. doi: 10.1371/journal.pntd.0000709

Figure 1. Patient flow chart.

Figure 1

*Excluded from the efficacy analysis: 24 patients were lost to follow-up, and three died (n = 2 deaths unrelated to VL and n = 1 death related to VL). Patients who were given rescue medication or who had died from VL were considered treatment failures; i.e. efficacy complete-case analysis set for SSG, n = 116 and for PM, n = 127.